Rita F. Redberg, MS, MD


Dr. Rita F. Redberg is a cardiologist who practices general and preventive cardiology. She is passionate about helping patients adopting positive lifestyle behaviors to reduce cardiac risk and stay healthy. She is also interested in how to promote high-value health care, an approach that emphasizes delivering appropriate treatment while avoiding tests or therapies with no known benefit.

Redberg studies how the assessment of medical technology for safety and effectiveness influences — and is influenced by — public health policy. In particular, she studies high-risk medical devices and women's inclusion in clinical trials for such devices.

As editor of JAMA Internal Medicine, a journal of the American Medical Association, she has spearheaded the publication's new focus on health care reform and less-is-more medicine, a movement to reduce unnecessary interventions.

Redberg earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania. She then completed a residency in internal medicine and a fellowship in cardiology at Columbia University Medical Center. She next completed a fellowship in noninvasive cardiology with the Mount Sinai Health System. Redberg also has a master of science degree in health policy and administration from the London School of Economics.


Cardiovascular Care and Prevention Center at Mission Bay
535 Mission Bay Blvd. South
San Francisco, CA 94158
Phone: (415) 353-2873
Fax: (415) 353-2528

Hours: Monday to Friday
8 a.m. – 5 p.m.

Academic Title


More about Rita F. Redberg


London School of Economics, M.S., Health Policy and Administration 1981
Perelman School of Medicine 1982


Columbia University Medical Center, Internal Medicine 1985


Columbia University Medical Center, Cardiology 1987
Mount Sinai Health System, Noninvasive Cardiology 1988

Selected Research and Publications

  1. Shakil S, Redberg RF. New (Very High) Prices on Old Drugs. JAMA Intern Med. 2017 Sep 11.
  2. Steinbrook R, Redberg RF. Sharing Medicine-A JAMA Internal Medicine Series. JAMA Intern Med. 2017 Sep 01; 177(9):1256.
  3. Adeboyeje G, Sylwestrzak G, Barron JJ, White J, Rosenberg A, Abarca J, Crawford G, Redberg R. Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation. J Manag Care Spec Pharm. 2017 Sep; 23(9):968-978.
  4. Dhruva SS, Mazure CM, Ross JS, Redberg RF. Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices. JAMA Intern Med. 2017 Sep 01; 177(9):1390-1391.
  5. Redberg RF. Continued High Rates of IVC Filter Use After US Food and Drug Safety Warning. JAMA Intern Med. 2017 Sep 01; 177(9):1374-1375.
  6. Redberg RF, O'Malley PG. Inaccuracies Describing Results of a Lung Cancer Screening Demonstration Project-Reply. JAMA Intern Med. 2017 Sep 01; 177(9):1397.
  7. Redberg RF, Prasad V. Evolocumab in Patients with Cardiovascular Disease. N Engl J Med. 2017 08 24; 377(8):786-7.
  8. Zheng SY, Dhruva SS, Redberg RF. Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements. JAMA. 2017 Aug 15; 318(7):619-625.
  9. Bauer SR, Redberg RF. Setting the Record Straight on FDA Approvals in Oncology-Reply. JAMA Intern Med. 2017 Aug 01; 177(8):1223.
  10. Sun BC, Redberg RF. Cardiac Testing After Emergency Department Evaluation for Chest Pain: Time for a Paradigm Shift? JAMA Intern Med. 2017 Aug 01; 177(8):1183-1184.
  11. Redberg RF, Jacoby AF, Sharfstein JM. Power Morcellators, Postmarketing Surveillance, and the US Food and Drug Administration. JAMA. 2017 Jul 25; 318(4):325-326.
  12. Bairey Merz CN, Andersen H, Sprague E, Burns A, Keida M, Walsh MN, Greenberger P, Campbell S, Pollin I, McCullough C, Brown N, Jenkins M, Redberg R, Johnson P, Robinson B. Knowledge, Attitudes, and Beliefs Regarding Cardiovascular Disease in Women: The Women's Heart Alliance. J Am Coll Cardiol. 2017 Jul 11; 70(2):123-132.
  13. Heidecker B, Spencer RM, Hayes V, Hall S, Parikh N, Stock EO, Redberg R. High Prevalence and Clinical/Sociodemographic Correlates of Miscarriages Among Flight Attendants. Am J Med. 2017 Jun 15.
  14. Grady D, Redberg RF. Physician Adherence to Breast Cancer Screening Recommendations. JAMA Intern Med. 2017 Jun 01; 177(6):763-764.
  15. Schoenfeld AJ, Redberg RF. The Value of Using Registries to Evaluate Randomized Clinical Trial Study Populations. JAMA Intern Med. 2017 Jun 01; 177(6):889.
  16. Dhruva SS, Redberg RF. FDA Drug Trials Snapshots-A Clearer Picture. JAMA Intern Med. 2017 May 01; 177(5):727.
  17. Shakil S, Redberg RF. Gender Disparities in Sponsorship-How They Perpetuate the Glass Ceiling. JAMA Intern Med. 2017 Apr 01; 177(4):582.
  18. Redberg RF. JAMA Internal Medicine-The Year in Review, 2016. JAMA Intern Med. 2017 Apr 01; 177(4):469-470.
  19. Steinbrook R, Katz MH, Redberg RF. Advancing the Needs of Patients in the Trump Era. JAMA Intern Med. 2017 Apr 01; 177(4):465-466.
  20. Redberg RF. Update in Cardiology: Evidence Published in 2016. Ann Intern Med. 2017 Apr 04; 166(7):W16-W19.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.